0000908662-15-000097.txt : 20150226
0000908662-15-000097.hdr.sgml : 20150226
20150226162909
ACCESSION NUMBER: 0000908662-15-000097
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150226
FILED AS OF DATE: 20150226
DATE AS OF CHANGE: 20150226
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYAX CORP
CENTRAL INDEX KEY: 0000907562
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043053198
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803-2756
BUSINESS PHONE: 617-250-5769
MAIL ADDRESS:
STREET 1: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803-2756
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTAGE INC
DATE OF NAME CHANGE: 19951117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ashe Andrew D.
CENTRAL INDEX KEY: 0001573163
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24537
FILM NUMBER: 15652944
MAIL ADDRESS:
STREET 1: C/O DYAX CORP.
STREET 2: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-02-26
0000907562
DYAX CORP
DYAX
0001573163
Ashe Andrew D.
C/O DYAX CORP.
55 NETWORK DRIVE
BURLINGTON
MA
01803-2756
0
1
0
0
General Counsel & EVP
Common Stock
2015-02-26
4
S
0
1500
15.34
D
36527
D
The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan. The sales were primarily intended to provide liquidity sufficient to cover tax obligations due in connection with the vesting of restricted stock.
Includes 1,750 shares acquired under Dyax Corp.'s 1998 Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(c).
/s/ Stacie S. Aarestad as attorney-in-fact
2015-02-26